FB LinkEdIn Instagram

News & Events
News

May 22, 2023
"AI is expected to raise the level of the labor market as a whole in terms of creativity and productivity"
8Prof. Avigdor Gal from the Faculty of Data and Decision Sciences: "AI is expected to raise the level of the labor market as a whole in terms of creativity and productivity" article
May 14, 2023
Prof. Shai Shen-Orr is interviewed in an article about The Human Immunome Project
Picture of Prof. Shai Shen-Orr is interviewed in an article about The Human Immunome Project
Prof. Shai Shen-Orr from the Rapaport Faculty of Medicine is interviewed in an article about The Human Immunome Project. article    
May 10, 2023
Technion and the University of Toronto launch a new collaboration
Picture of Technion and the University of Toronto launch a new collaboration
Technion and the University of Toronto Artificial Intelligence Centers launch a new collaboration to develop AI solutions in the field of medicine. article
March 21, 2023
Roi Shamir created Haggad.AI with his friend Yitzhak Wolf
Picture of Roi Shamir created Haggad.AI with his friend Yitzhak Wolf
Graduate of the Faculty of Architecture and Urban Planning Roi Shamir created Haggad.AI with his friend Yitzhak Wolf - the first Haggadah in AI. Meet Haggad.AI, the world’s first Haggadah created by artificial intelligence  
March 15, 2023
Harnessing the Power of AI: Putting theory into practice Meetup
Harnessing the Power of AI: Putting theory into practice @Haifa Tickets, Wed, Mar 15, 2023 at 4:30 PM | Eventbrite article
March 3, 2023
The annual conference of Tech.AI, Technion's Artificial Intelligence Hub
Picture of The annual conference of Tech.AI, Technion's Artificial Intelligence Hub
The annual conference of Tech.AI, Technion's Artificial Intelligence Hub, opened with an expert panel moderated by Hila Korach. Prospects and Risks from the Forefront of AI
February 26, 2023
Prof. Yaniv Romano and his colleagues at MIT on the limits of uncertainty
Picture of Prof. Yaniv Romano and his colleagues at MIT on the limits of uncertainty
Prof. Yaniv Romano from the Taub Faculty of Computer Science and his colleagues at MIT on the limits of uncertainty. article  
February 1, 2023
How to combine scientific experiments with algorithmics and intelligence Artificial
Dr. Kira Radinsky: "We try to identify with the help of medical files when to make a pro-active appointment"

https://m.calcalist.co.il/Article.aspx?guid=sjpcruuhs&utm_source=m.calcalist.co.il&utm_medium=Share&utm_term=sjpcruuhs&utm_campaign=whatsapp [caption id="attachment_3183" align="aligncenter" width="300"] Dr. Kira Radinsky[/caption]  
January 29, 2023
The Limits of Uncertainty
Prof. Yaniv Romano from the Faculty of Electrical and Computer Engineering and his colleagues at MIT on the limits of uncertainty https://infovalue.online/placing-clear-bounds-on-uncertainty-mit-information/ [caption id="attachment_3064" align="aligncenter" width="200"] Prof. Yaniv Romano of the Faculty of Electrical and Computer Engineering, Technion[/caption]
January 15, 2023
Technion & Pfizer to Collaborate
Technion-Israel Institute of Technology and Pfizer, one of the world’s premier biopharmaceutical companies, recently signed a collaboration framework agreement to identify opportunities to collaborate and bring forward scientific breakthroughs at the interface between artificial intelligence and drug development. The framework agreement was finalized during the visit of a delegation from Pfizer to the Technion. The delegation was led by Pfizer Chairman and CEO, Dr. Albert Bourla, and included Dr. Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical; Lidia Fonseca, Executive Vice President and Chief Digital and Technology Officer; and other senior executives. Pfizer leaders met with the Technion President Professor Uri Sivan, members of the Technion’s senior management and Technion faculty members from the fields of life sciences and engineering. Pfizer, a biopharmaceutical company with 170 years of experience developing innovative medicines and vaccines, has made an enormous impact on global health in recent years through its development, with BioNTech, of vaccines that help protect against the COVID-19 virus. In addition to its internal drug discovery efforts, Pfizer regularly collaborates with the biotech industry and academia to identify research and technologies that could lead to scientific breakthroughs. The framework agreement with the Technion is consistent with the Institute’s ambition to advance technological and medical developments.

The Pfizer delegation led by Pfizer Chairman and CEO, Dr. Albert Bourla with the Technion delegation led by Technion President Professor Uri Sivan

“Human health is one of the grand challenges facing humanity in the 21st century,” said Technion President Prof. Uri Sivan. “Like other global challenges, today’s scientific and technological breakthroughs require multidisciplinary research and close cooperation between academia and industry. We recently launched Tech.AI, Technion’s Artificial Intelligence Hub, to serve as the main Technion platform providing faculty & students from all Technion units with the best possible access to the forefront of AI research and application. Cooperation with industry, where the great challenges lie, is vital to an undertaking of this kind, and I am therefore looking forward to Pfizer’s potential contributions to this mission.” During their visit, the guests met leading Technion researchers working in the field of AI in the context of human health: Associate Professor Shai Shen-Orr from the Rappaport Faculty of Medicine; Professor Tomer Shlomi from the Henry and Marilyn Taub Faculty of Computer Science; Assistant Professor Dvir Aran from the Faculty of Biology and the Taub Faculty of Computer Science; Assistant Professor Noga Ron-Harel from the Faculty of Biology; and Assistant Professor Uri Shalit from the Faculty of Data and Decision Sciences. According to Prof. Shai Shen-Orr, “the Technion is a leading institution in the field of AI, ranked first in Europe in this field by CS ranking. Our Tech.AI center brings together the Technion’s activity in this field. We are extremely thrilled with the agreement with Pfizer, which will offer Technion researchers close encounters with real-world challenges in drug development, help identify potential applications of AI to drug research and development and expand the Technion’s capabilities in translational research.”